GRAL
Price:
$63.44
Market Cap:
$2.72B
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal r...[Read more]
Industry
Biotechnology
IPO Date
2024-06-12
Stock Exchange
NASDAQ
Ticker
GRAL
According to GRAIL Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.70B. This represents a change of 17.31% compared to the average of 2.31B of the last 4 quarters.
The mean historical Enterprise Value of GRAIL Inc. over the last ten years is 1.13B. The current 2.70B Enterprise Value has changed 23.80% with respect to the historical average. Over the past ten years (40 quarters), GRAL's Enterprise Value was at its highest in in the December 2025 quarter at 3.33B. The Enterprise Value was at its lowest in in the March 2024 quarter at -469980046.88.
Average
1.13B
Median
944.96M
Minimum
278.59M
Maximum
2.99B
Discovering the peaks and valleys of GRAIL Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 607.23%
Maximum Annual Enterprise Value = 2.99B
Minimum Annual Increase = -80.18%
Minimum Annual Enterprise Value = 278.59M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 2.99B | 607.23% |
| 2024 | 423.34M | 2.93% |
| 2023 | 411.30M | 47.63% |
| 2022 | 278.59M | -11.16% |
| 2021 | 313.58M | -80.18% |
| 2020 | 1.58B | 0.03% |
| 2019 | 1.58B | 7.84% |
The current Enterprise Value of GRAIL Inc. (GRAL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.28B
5-year avg
884.17M
10-year avg
1.13B
GRAIL Inc.’s Enterprise Value is less than Dyne Therapeutics, Inc. (3.96B), less than Ultragenyx Pharmaceutical Inc. (3.49B), less than Apogee Therapeutics, Inc. (7.86B), less than Xenon Pharmaceuticals Inc. (5.56B), less than Centessa Pharmaceuticals plc (6.21B), less than Envista Holdings Corp (5.12B), less than Ascentage Pharma Group International (11.01B), less than Celcuity Inc. (4.11B), greater than Soleno Therapeutics, Inc. (2.63B), less than IDEAYA Biosciences, Inc. (3.26B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 3.96B | $4.61B | |
| 3.49B | $2.46B | |
| 7.86B | $8.30B | |
| 5.56B | $6.10B | |
| 6.21B | $6.27B | |
| 5.12B | $4.62B | |
| 11.01B | $1.70B | |
| 4.11B | $4.06B | |
| 2.63B | $2.76B | |
| 3.26B | $3.38B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GRAIL Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like GRAIL Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is GRAIL Inc.'s Enterprise Value?
What is the highest Enterprise Value for GRAIL Inc. (GRAL)?
What is the 3-year average Enterprise Value for GRAIL Inc. (GRAL)?
What is the 5-year average Enterprise Value for GRAIL Inc. (GRAL)?
How does the current Enterprise Value for GRAIL Inc. (GRAL) compare to its historical average?